Yuriko Nagane Selected Research

Thymus Hyperplasia

1/2018	Rationale for the clinical guidelines for myasthenia gravis in Japan.
11/2016	Response to treatment of myasthenia gravis according to clinical subtype.
1/2014	Insights into the classification of myasthenia gravis.
1/2003	Interleukin-2 production by peripheral blood mononuclear cells from patients with myasthenia gravis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuriko Nagane Research Topics

Disease

23	Myasthenia Gravis 01/2020 - 01/2002
7	Thymoma (Thymic Carcinoma) 11/2016 - 08/2007
4	Thymus Hyperplasia 01/2018 - 01/2003
3	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 07/2011
3	Hypoxia (Hypoxemia) 04/2005 - 05/2002
2	Myocarditis (Carditis) 01/2011 - 08/2007
2	Myositis (Idiopathic Inflammatory Myopathies) 11/2009 - 08/2007
2	Guillain-Barre Syndrome 09/2006 - 01/2003
1	Muscle Weakness 01/2017
1	Osteoporosis 01/2015
1	Osteoporotic Fractures 01/2015
1	Hypertension (High Blood Pressure) 01/2012
1	Blepharoptosis (Ptosis, Eyelid) 07/2011
1	Rhabdomyosarcoma 08/2007
1	Hyperplasia 07/2007
1	Herpes Zoster 09/2006
1	Hypesthesia (Numbness) 09/2006
1	Chronic Hepatitis C 06/2005
1	Muscular Diseases (Myopathy) 06/2005
1	Hypothyroidism 06/2005
1	Hepatitis A (Hepatitis, Infectious) 01/2003
1	Pheochromocytoma 05/2002

Drug/Important Bio-Agent (IBA)

8	Cholinergic ReceptorsIBA 11/2016 - 01/2003
7	AntibodiesIBA 01/2018 - 01/2003
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 01/2011
6	AutoantibodiesIBA 01/2017 - 08/2007
5	Prednisolone (Predate)FDA LinkGeneric 01/2018 - 01/2005
3	Calcineurin InhibitorsIBA 01/2012 - 02/2010
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 01/2010
3	Tacrolimus (Prograf)FDA LinkGeneric 02/2010 - 02/2003
2	SteroidsIBA 01/2020 - 01/2010
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2017 - 09/2012
2	Methylprednisolone FDA LinkGeneric 01/2011 - 01/2002
2	ConnectinIBA 01/2011 - 11/2009
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2011 - 11/2009
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 02/2010 - 11/2009
2	phytobacteriomycin (PBM)IBA 02/2003 - 01/2003
2	Interleukin-2 (IL2)IBA 02/2003 - 01/2003
2	PhytohemagglutininsIBA 02/2003 - 01/2003
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 11/2016
1	GlucocorticoidsIBA 01/2015
1	Immunologic Factors (Immunomodulators)IBA 05/2013
1	Indicators and Reagents (Reagents)IBA 09/2012
1	CreatinineIBA 01/2012
1	glucose-regulated proteinsIBA 08/2011
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 07/2011
1	Naphazoline (All Clear)FDA LinkGeneric 07/2011
1	Muscle Proteins (Muscle Protein)IBA 01/2011
1	EpitopesIBA 01/2011
1	2-methylphenyl cinnamateIBA 01/2010
1	SulfurIBA 08/2007
1	Protein Kinase CIBA 07/2007
1	Protein Kinase C-thetaIBA 07/2007
1	AntigensIBA 07/2007
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2006
1	thyrotropin-binding inhibitory immunoglobulinIBA 06/2005
1	Interferon-alpha (Interferon Alfa)IBA 06/2005
1	Thyroid HormonesIBA 06/2005
1	Angiotensin IIIBA 04/2005
1	HLA-DR Antigens (HLA-DR)IBA 05/2003
1	Sulfoglycosphingolipids (Sulfatides)IBA 01/2003
1	Neuroprotective AgentsIBA 11/2002
1	Nicotine FDA Link 05/2002
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 05/2002

Therapy/Procedure

7	Therapeutics 01/2020 - 01/2002
4	Thymectomy 01/2018 - 01/2003
1	Adjuvant Radiotherapy 05/2013
1	Plasmapheresis 01/2011
1	Immunomodulation 11/2009
1	Aftercare (After-Treatment) 01/2005